February 10, 2000
Honorable Don Nickles
Assistant Majority Leader
United States Senate
Washington, DC 20510
Dear Senator:
At the request of several Members, the Congressional Budget Office is preparing cost estimates for S. 1344, the Patients' Bill of Rights Act, as passed by the Senate, and the Bipartisan Consensus Managed Care Improvement Act, contained within H.R. 2990, as passed by the House.
Although CBO and the Joint Committee on Taxation have not yet completed estimates of the budgetary effects of those bills, CBO has estimated their long-run effects on the premiums for employer-sponsored health plans. We estimate that enacting S. 1344 would increase such premiums by an average of 1.3 percent, and that enacting H.R. 2990 would increase premiums by an average of 4.1 percent. The attached tables delineate the impact on premiums of various provisions of the two bills.
I hope this information is helpful to you. The CBO staff contacts are Tom Bradley and Judith Wagner. We expect to transmit the completed cost estimates shortly.
Sincerely,
Dan L. Crippen
Attachments
Identical letters sent to Honorable James M. Jeffords, Honorable Tom Bliley,
Honorable John D. Dingell, Honorable Bill Archer, Honorable John A. Boehner,
Honorable Charlie Norwood
ESTIMATED ULTIMATE EFFECT OF S. 1344, THE PATIENTS' BILL OF RIGHTS ACT, ON PREMIUMS FOR EMPLOYER-SPONSORED HEALTH INSURANCE (In percent) | |||
Provision | Increase in Premiums | ||
| |||
Title I | |||
Subtitle A--Right to Medical Advice and Care | |||
Access to emergency care | 0.2 | ||
Offering choice of coverage options | 0.2 | ||
Access to obstetric and gynecological care | a | ||
Access to pediatric care | a | ||
Access to specialists | 0.1 | ||
Continuity of care | 0.2 | ||
Protection of patient-provider communications | a | ||
Right to prescription drugs | a | ||
Self-payment for behavioral health care services | a | ||
Coverage for cancer clinical trials | 0.1 | ||
Prohibiting discrimination against providers | a | ||
Subtitle B--Right to Information About Plans and Providers | a | ||
Subtitle C--Right to Hold Health Plans Accountable | 0.3 | ||
Title II | |||
Women's Health and Cancer Rights | 0.2 | ||
Title III | |||
Genetic Information and Services | a | ||
Total | 1.3 | ||
| |||
SOURCE: Congressional Budget Office. | |||
NOTE: S. 1344, as passed by the Senate on July 15, 1999. | |||
a. Less than 0.05 percent. | |||
|
ESTIMATED ULTIMATE EFFECT OF THE BIPARTISAN CONSENSUS MANAGED CARE IMPROVEMENT ACT ON PREMIUMS FOR EMPLOYER-SPONSORED HEALTH INSURANCE (In percent) | |||
Provision | Increase in Premiums | ||
| |||
Title XIa | |||
Subtitle A--Grievances and Appeals | |||
Utilization review activities | 0.2 | ||
Internal and external appeals | 1.3 | ||
Establishment of grievance process | b | ||
Subtitle B--Access to Care | |||
Consumer choice | 0.2 | ||
Choice of health care professional | b | ||
Access to emergency care | 0.4 | ||
Access to specialty care | b | ||
Access to obstetric and gynecological care | 0.1 | ||
Access to pediatric care | b | ||
Continuity of care | 0.3 | ||
Access to needed drugs | b | ||
Clinical trials | 0.5 | ||
Subtitle C--Access to Information | b | ||
Subtitle D--Protecting the Doctor-Patient Relationship | |||
Prohibition of interference with communications | b | ||
Prohibition of discrimination based on licensure | b | ||
Prohibition against improper incentive arrangements | b | ||
Payment of claims | b | ||
Protection for patient advocacy | b | ||
Title XIII | |||
ERISA Liability Preemption | 1.0 | ||
Total | 4.1 | ||
| |||
SOURCE: Congressional Budget Office. | |||
NOTES: The Bipartisan Consensus Managed Care Improvement Act, as passed by the House of Representatives on October 6, 1999 (as part of H.R. 2990). | |||
ERISA = Employee Retirement Income Security Act | |||
a. Figures include impacts on group health plans and group health insurance coverage under the Public Health Service Act (resulting from the provisions of Title XII) and the Employee Retirement Income Security Act of 1974 (resulting from the provisions of Title XIII). | |||
b. Less than 0.05 percent. | |||
|